Precision medicine in type 1 diabetes

被引：29

作者：

Carr, Alice L. J. ^{[1
]}

Evans-Molina, Carmella ^{[2
,3
,4
,5
,6
,7
,8
]}

Oram, Richard A. ^{[1
]}

机构：

[1] Univ Exeter, Inst Biomed & Clin Sci, Med Sch, Exeter, Devon, England

[2] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA

[3] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA

[4] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA

[5] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA

[6] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA

[7] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA

[8] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA

来源：

DIABETOLOGIA | 2022年 / 65卷 / 11期

关键词：

Continuous glucose monitoring; C-peptide; Genetics; Insulin; Personalised medicine; Precision medicine; Review; Type; 1; diabetes; LOOP INSULIN DELIVERY; BETA-CELL FUNCTION; GENETIC RISK SCORE; C-PEPTIDE LEVELS; YOUNG-PEOPLE; ISLET AUTOANTIBODIES; CLINICAL UTILITY; GLYCEMIC CONTROL; PUMP THERAPY; CHILDREN;

D O I：

10.1007/s00125-022-05778-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

First envisioned by early diabetes clinicians, a person-centred approach to care was an aspirational goal that aimed to match insulin therapy to each individual's unique requirements. In the 100 years since the discovery of insulin, this goal has evolved to include personalised approaches to type 1 diabetes diagnosis, treatment, prevention and prediction. These advances have been facilitated by the recognition of type 1 diabetes as an autoimmune disease and by advances in our understanding of diabetes pathophysiology, genetics and natural history, which have occurred in parallel with advancements in insulin delivery, glucose monitoring and tools for self-management. In this review, we discuss how these personalised approaches have improved diabetes care and how improved understanding of pathogenesis and human biology might inform precision medicine in the future.

引用

页码：1854 / 1866

页数：13

共 143 条

[81] Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories [J].

Kwon, Bum Chul ;

Anand, Vibha ;

Achenbach, Peter ;

Dunne, Jessica L. ;

Hagopian, William ;

Hu, Jianying ;

Koski, Eileen ;

Lernmark, Ake ;

Lundgren, Markus ;

Ng, Kenney ;

Toppari, Jorma ;

Veijola, Riitta ;

Frohnert, Brigitte, I .

NATURE COMMUNICATIONS, 2022, 13 (01)

[82] Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial [J].

Lachin, John M. ;

McGee, Paula ;

Palmer, Jerry P. .

DIABETES, 2014, 63 (02) :739-748

[83] Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study [J].

Lachin, John M. ;

Orchard, Trevor J. ;

Nathan, David M. .

DIABETES CARE, 2014, 37 (01) :39-43

[84] A diabetic diet - The line ration scheme [J].

Lawrence, RD .

BRITISH MEDICAL JOURNAL, 1925, 1925 :261-262

[85] Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis [J].

Leete, Pia ;

Oram, Richard A. ;

McDonald, Timothy J. ;

Shields, Beverley M. ;

Ziller, Clemens ;

Hattersley, Andrew T. ;

Richardson, Sarah J. ;

Morgan, Noel G. .

DIABETOLOGIA, 2020, 63 (06) :1258-1267

[86] Differential Insulitic Profiles Determine the Extent of -Cell Destruction and the Age at Onset of Type 1 Diabetes [J].

Leete, Pia ;

Willcox, Abby ;

Krogvold, Lars ;

Dahl-Jorgensen, Knut ;

Foulis, Alan K. ;

Richardson, Sarah J. ;

Morgan, Noel G. .

DIABETES, 2016, 65 (05) :1362-1369

[87] Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years [J].

Lynam, Anita ;

McDonald, Timothy ;

Hill, Anita ;

Dennis, John ;

Oram, Richard ;

Pearson, Ewan ;

Weedon, Michael ;

Hattersley, Andrew ;

Owen, Katharine ;

Shields, Beverley ;

Jones, Angus .

BMJ OPEN, 2019, 9 (09)

[88] PREVALENCE OF RESIDUAL BETA-CELL FUNCTION IN INSULIN-DEPENDENT DIABETICS IN RELATION TO AGE AT ONSET AND DURATION OF DIABETES [J].

MADSBAD, S ;

FABER, OK ;

BINDER, C ;

MCNAIR, P ;

CHRISTIANSEN, C ;

TRANSBOL, I .

DIABETES, 1978, 27 :262-264

[89] Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice? [J].

Marren, S. M. ;

Hammersley, S. ;

McDonald, T. J. ;

Shields, B. M. ;

Knight, B. A. ;

Hill, A. ;

Bolt, R. ;

Tree, T. I. ;

Roep, B. O. ;

Hattersley, A. T. ;

Jones, A. G. ;

Oram, R. A. .

DIABETIC MEDICINE, 2019, 36 (09) :1092-1099

[90] EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature [J].

McDonald, Timothy J. ;

Perry, Mandy H. ;

Peake, Roy W. A. ;

Pullan, Nicola J. ;

O'Connor, John ;

Shields, Beverley M. ;

Knight, Beatrice A. ;

Hattersley, Andrew T. .

PLOS ONE, 2012, 7 (07)

← 4 5 6 7 8 9 10 11 12 13 →